Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Rolling NDA submission continues for Onco TCS

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Dec. 4, 2003

AxyS and Cytovia patent novel caspase activators for use as antitumor agents

Dec. 4, 2003

First approval for Erbitux granted by Swiss authorities

Dec. 3, 2003

FDA accepts Avastin BLA for priority review

Dec. 3, 2003

In vitro efficacy of 2-methoxyestradiol in prostate and pancreatic cancer

Dec. 3, 2003

Antiproliferative and cytotoxic effects of aplidine assessed in human cancer cell lines

Dec. 3, 2003

Preclinical and clinical antitumor efficacy and clinical safety of Bay-43-9006

Dec. 3, 2003

Radiosensitizing effects of GW-572016 and use in combination chemotherapy

Dec. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...